This Morning's Research Reports on Specialty Chemicals Stocks -- Chemours, Venator Materials, W.R. Grace, and Yield10 Bioscience

NEW YORK, Feb. 26, 2018 /PRNewswire/ --

WallStEquities.com strives to bring the best free research to the investment community.  Today we are offering reports on CC, VNTR, GRA, and YTEN which can be accessed for free by signing up to www.wallstequities.com/registration. For today, WallStEquities.com turns attention to The Chemours Co. (NYSE: CC), Venator Materials PLC (NYSE: VNTR), W. R. Grace & Co. (NYSE: GRA), and Yield10 Bioscience Inc. (NASDAQ: YTEN). These companies are part of the global Specialty Chemicals market, which, on the basis of type, can be broadly segmented into adhesives and sealants, catalysts, construction chemicals, cosmetic chemicals, and dyes, among many others. All you have to do is sign up today for this free limited time offer by clicking the link below. www.wallstequities.com/registration

Chemours

Last Friday, shares in Wilmington, Delaware headquartered The Chemours Co. ended the session 1.87% higher at $51.08. The stock recorded a trading volume of 1.66 million shares. The Company's shares have advanced 49.93% over the past year. The stock is trading above its 50-day and 200-day moving averages by 1.69% and 6.15%, respectively. Furthermore, shares of Chemours, which provides performance chemicals in North America, Asia/Pacific, EMEA region, and Latin America, have a Relative Strength Index (RSI) of 56.45.  

On January 30^th, 2018, research firm Morgan Stanley initiated an 'Equal-Weight' rating on the Company's stock, with a target price of $57.50 per share.

On February 15^th, 2018, Chemours announced that Chris Siemer, President of Chemical Solutions and Chief Transformation Officer, has announced his intention to leave the Company following a brief transition period. Effective April 01^st, 2018, Edwin Sparks, currently Director of Corporate Strategy, will be promoted to the role of President - Chemical Solutions. Get the full research report on CC for free by clicking below at: www.wallstequities.com/registration/?symbol=CC

Venator Materials

The Woodlands, Texas headquartered Venator Materials PLC's stock finished 7.43% lower at $19.55. A total volume of 3.19 million shares was traded, which was above their three months average volume of 1.29 million shares. The Company's shares are trading below their 200-day moving average by 11.96%. Moreover, shares of Venator Materials, which manufactures and markets chemical products worldwide, have an RSI of 33.22.  

On January 30^th, 2018, research firm Morgan Stanley initiated an 'Equal-Weight' rating on the Company's stock.

On February 23^rd, 2018, Venator Materials reported its Q4 and full-year 2017 results. Q4 2017 highlights included net income attributable to the Company of $68 million, adjusted EBITDA of $118 million, and net cash provided by operating activities from continuing operations of $157 million. Full year 2017 highlights included net cash provided by operating activities of $337, free cash flow of $212 million, and net debt of $519 million. Download our actionable research report on VNTR at: www.wallstequities.com/registration/?symbol=VNTR

W.R. Grace

Shares in Columbia, Maryland headquartered W.R. Grace & Co. closed the day 1.80% higher at $67.72. The stock recorded a trading volume of 433,527 shares. The Company's shares are trading below their 50-day moving average by 4.42%. Moreover, shares of W.R. Grace, which produces and sells specialty chemicals and materials worldwide, have an RSI of 44.36.  

On February 08^th, 2018, W.R. Grace announced that its Board of Directors has approved a 14% increase in the Company's regular annual cash dividend from $0.84 to $0.96 per common share. The increase will be effective with the Q1 dividend of $0.24 per common share, and is payable on March 22^nd, 2018, to shareholders of record at the close of business on March 01^st, 2018. Register for your free report coverage on GRA at: www.wallstequities.com/registration/?symbol=GRA

Yield10 Bioscience

Woburn, Massachusetts headquartered Yield10 Bioscience Inc.'s shares recorded a trading volume of 185,833 shares last Friday. The stock closed 0.65% higher at $1.55. The Company's shares are trading 23.04% below their 50-day moving average. Additionally, shares of Yield10 Bioscience, which engages in developing disruptive technologies for enhancing crop yield in the US, have an RSI of 42.14. Get the free research report on YTEN at: www.wallstequities.com/registration/?symbol=YTEN

Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

WSE has not been compensated; directly or indirectly; for producing or publishing this document. 

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email [email protected]. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  

NO WARRANTY

WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit https://wallstequities.com/legal-disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: [email protected]
Phone number: +21-32-044-483
Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Wall St. Equities